I’ve received one of AMD’s first official AI developer boxes for testing, and it’s an impressive piece of AI hardware with a ...

Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) has become the semiconductor story of 2026. Shares are up 152.56% year-to-date, driven by an AI infrastructure buildout that keeps expanding ...

But as organizations gain experience with generative AI, many are discovering that the endpoint itself is becoming an ...

AMD EPYC is poised for the AI CPU supercycle, powering inference and agentic AI with strong TCO and efficiency—alongside Instinct & Helios. Click for this update.

Shares of Advanced Micro Devices (NASDAQ:AMD) traded near $521 midmorning Wednesday, roughly flat on the session after a ...

Could the bullishness around AMD's stock continue this year? The latter part of this year could be a crucial time for AMD. Back in February, CEO Lisa Su said that the second half of the year would be ...

The fixed idea that DNA is only a molecule that stores genetic information is being challenged. KAIST researchers have developed a technology that controls the chemical environment around catalysts at ...

A single-atom platinum catalyst lights ammonia at 200 °C and keeps it burning steadily at 1,100 °C with low NO x, generating high-grade, carbon-free heat for steel, cement and chemicals. Ammonia is a ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...

Advanced Micro Devices shares have run up on optimism for the company’s server central processing units, but one analyst now isn’t sure that it will be able to recognize much more upside from the ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.